Conatus Pharmaceuticals - Stock Price History | CNAT

Historical daily share price chart and data for Conatus Pharmaceuticals since 2019 adjusted for splits. The latest closing stock price for Conatus Pharmaceuticals as of November 18, 2019 is 0.33.
  • The all-time high Conatus Pharmaceuticals stock closing price was 14.25 on January 10, 2014.
  • The Conatus Pharmaceuticals 52-week high stock price is 4.94, which is 1397% above the current share price.
  • The Conatus Pharmaceuticals 52-week low stock price is 0.25, which is 24.2% below the current share price.
  • The average Conatus Pharmaceuticals stock price for the last 52 weeks is 1.11.
Conatus Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 4.5332 4.7500 7.5000 1.1700 1.7300 -62.55%
2017 5.3061 5.3900 8.7700 3.9200 4.6200 -12.33%
2016 2.1749 2.9300 6.1100 1.5000 5.2700 82.99%
2015 5.0474 8.0900 10.6300 2.5900 2.8800 -58.86%
2014 7.8589 6.2600 14.2500 5.3200 7.0000 8.53%
2013 8.5407 9.5000 10.4900 5.9600 6.4500 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.011B $0.034B
Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $151.574B 27.65
Medtronic (MDT) Ireland $150.347B 21.10
Stryker (SYK) United States $77.159B 25.94
Boston Scientific (BSX) United States $58.973B 27.84
Baxter (BAX) United States $41.580B 25.21
EssilorLuxottica Societe Anonyme (ESLOY) France $33.594B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.190B 18.94
Terumo (TRUMY) Japan $26.583B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.587B 0.00
Coloplast (CLPBY) Denmark $25.207B 0.00
ResMed (RMD) United States $21.151B 39.02
Smith & Nephew SNATS (SNN) United Kingdom $18.898B 0.00
Sunny Optical Technology (SNPTF) China $17.275B 0.00
Insulet (PODD) United States $11.149B 530.41
Bio-Rad Laboratories (BIO) United States $10.653B 51.13
Hill-Rom Holdings (HRC) United States $7.014B 20.67
Perrigo (PRGO) Ireland $6.721B 12.53
William Demant Holdings (WILYY) Denmark $6.665B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.106B 41.26
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
Canopy Growth (CGC) Canada $5.342B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.819B 30.07
ICU Medical (ICUI) United States $3.606B 23.51
Neogen (NEOG) United States $3.404B 56.97
GW Pharmaceuticals (GWPH) United Kingdom $3.349B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.105B 0.00
Aurora Cannabis (ACB) Canada $2.809B 0.00
Quidel (QDEL) United States $2.674B 25.37
National Vision Holdings (EYE) United States $2.183B 49.27
Agios Pharmaceuticals (AGIO) United States $2.101B 0.00
InMode (INMD) Israel $1.581B 0.00
Cardiovascular Systems (CSII) United States $1.560B 0.00
VAREX IMAGING (VREX) United States $1.157B 23.18
AtriCure (ATRC) United States $1.144B 0.00
Aphria (APHA) $1.069B 0.00
Phibro Animal Health (PAHC) United States $0.938B 17.57
NanoString Technologies (NSTG) United States $0.876B 0.00
Lantheus Holdings (LNTH) United States $0.845B 21.12
TG Therapeutics (TGTX) United States $0.796B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.782B 29.95
LeMaitre Vascular (LMAT) United States $0.687B 38.63
PetIQ (PETQ) United States $0.679B 16.57
Omeros (OMER) United States $0.657B 0.00
Quanterix (QTRX) United States $0.643B 0.00
Cerus (CERS) United States $0.627B 0.00
Surmodics (SRDX) United States $0.536B 55.93
OraSure Technologies (OSUR) United States $0.494B 29.63
HEXO (HEXO) $0.460B 0.00
MacroGenics (MGNX) United States $0.423B 0.00
Owens & Minor (OMI) United States $0.418B 15.47
Utah Medical Products (UTMD) United States $0.371B 26.90
Meridian Bioscience (VIVO) United States $0.369B 12.71
Organigram Holdings (OGI) Canada $0.358B 0.00
BioLife Solutions (BLFS) United States $0.312B 127.08
Zynex (ZYXI) United States $0.303B 34.30
Neptune Wellness Solutions (NEPT) Canada $0.254B 0.00
Bovie Medical (APYX) United States $0.251B 0.00
Viemed Healthcare (VMD) United States $0.250B 0.00
Vapotherm (VAPO) United States $0.230B 0.00
United Health Products (UEEC) United States $0.222B 0.00
Repro-Med Systems (KRMD) United States $0.170B 0.00
Cytosorbents (CTSO) United States $0.135B 0.00
Rockwell Medical (RMTI) United States $0.134B 0.00
Fonar (FONR) United States $0.133B 9.36
Liberty Health Sciences (LHSIF) Canada $0.123B 0.00
Female Health (VERU) United States $0.123B 0.00
Chimerix (CMRX) United States $0.114B 0.00
United-Guardian (UG) United States $0.087B 22.00
Chembio Diagnostics (CEMI) United States $0.081B 0.00
Nephros (NEPH) United States $0.066B 0.00
MTech Acquisition (KERN) United States $0.065B 0.00
Surface Oncology (SURF) United States $0.051B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.035B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.016B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00